Saeirad Samira, LeDoux Mark S
Department of Psychology, University of Memphis, Memphis, TN, United States.
Veracity Neuroscience LLC, Memphis, TN, United States.
Dystonia. 2024;3. doi: 10.3389/dyst.2024.12016. Epub 2024 Feb 7.
In preceding work, a deleterious variant [GRCh38/hg38, NC_000008.11:g.22140245G>A, NM_025232.4:c.109C>T, p.Arg37Trp] was found to co-segregate with blepharospasm (BSP) in a large African-American pedigree. Other variants have been reported in genetic screening studies of dystonia. The paralogs, and are associated with spastic paraplegia. The causal contributions of variants to dystonia and other neurological disorders remains indecisive.
Sanger sequencing was used to screen subjects ( = 307) with BSP and BSP-plus dystonia affecting additional anatomical segments (BSP+) phenotypes for variants in tools were used to examine the deleteriousness of reported (ClinVar) and previously published variants.
No highly deleterious variant was identified in coding or contiguous splice site regions of in our cohort of 307 subjects. analysis identified numerous deleterious variants in published screening studies of dystonia and several highly deleterious single nucleotide variants in ClinVar.
Highly deleterious variants are rare in BSP and BSP+ phenotypes.
在之前的研究中,在一个大型非裔美国家系中发现一种有害变异[GRCh38/hg38,NC_000008.11:g.22140245G>A,NM_025232.4:c.109C>T,p.Arg37Trp]与眼睑痉挛(BSP)共分离。在肌张力障碍的基因筛查研究中还报告了其他变异。同源基因与痉挛性截瘫有关。这些变异对肌张力障碍和其他神经系统疾病的因果作用仍不明确。
采用桑格测序法对307例患有BSP和累及其他解剖节段的BSP加肌张力障碍(BSP+)表型的受试者进行筛查,以寻找基因变异。使用工具检查已报告(ClinVar)和先前发表的基因变异的有害性。
在我们的307例受试者队列中,未在基因的编码或相邻剪接位点区域鉴定出高度有害的变异。分析在已发表的肌张力障碍筛查研究中鉴定出许多有害的基因变异,在ClinVar中鉴定出几个高度有害 的单核苷酸变异。
高度有害的基因变异在BSP和BSP+表型中很少见。